Maintenance therapy following salvage ASCT for multiple myeloma Ravi Vij, MD, MBA, Washington University Medical School, St Louis, MO, discusses maintenance therapy following salvage autologous stem cell transplant (ASCT) in patients with multiple myeloma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Read More
Combined exercise, mindfulness training may help reduce fatigue in cancer survivors Combined exercise, mindfulness training may help reduce fatigue in cancer survivors | Photo Credit: Pixabay& Washington: Researchers at the University of Illinois Urbana-Champaign have found that a combination of exercise and mindfulness training can help reduce fatigue in breast cancer survivors. The results from […]
Read More
Five markers identified for diagnosing ovarian cancer 53-year-old Sheila (name changed) noticed abdominal pain as she woke up one morning. With her daughter’s marriage due in a month and preparations underway, Sheila dismissed it. After the wedding, when the guests had departed, the frequency of her pains increased, and she visited her gynaecologist. The gynaecologist […]
Read More
Low-dose CT for lung cancer screening: Benefit outweighs potential harm Washington [US], December 4 (ANI): According to a recent study, for heavy smokers, lung cancer screening using low-dose computed tomography (low-dose CT, LDCT) offers more benefit than harm.The procedure can save a number of people from dying of lung cancer; for some of them, it […]
Read More
Celyad Oncology Announces Dosing of First Patient in Phase 1 IMMUNICY-1 Trial of CYAD-211 for … Preliminary data from the Phase 1 trial are expected first half 2021 Additional €3.4 million in non-dilutive funding from SPW-Recherche of the Walloon Region to support advancement of CYAD-211 MONT-SAINT-GUIBERT, Belgium, Dec. 04, 2020 (GLOBE NEWSWIRE) — Celyad Oncology […]
Read More
Liposomal Doxorubicin Market Quality & Quantity Analysis | Johnson & Johnson, Sun … North America, Europe, China, Japan, Rest of the World, September 2020,– – The Liposomal Doxorubicin Market research report includes an in-sight study of the key Global Liposomal Doxorubicin Market prominent players along with the company profiles and planning adopted by them. This helps the buyer of the […]
Read More
Antengene submits NDAs for XPOVIO (Selinexor) in multiple APAC markets Aims to treat adult patients with “relapsed or refractory multiple myeloma (rrMM)” and “relapsed or refractory diffuse large B-cell lymphoma (rrDLBCL)” in Singapore, Australia, Hong Kong and South Korea Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class […]
Read More